Summary

PRA Health Sciences’ Strategic Solutions Division (SSD) understands the critical importance of Investigator-Initiated Trials and the value they create in improving the treatment of disease, patient outcomes, healthcare quality, and the long term success of a product’s commercialization life cycle.

Register to download

Investigator-Initiated Trials Program Management